[Form 4] Enact Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Sheila Hooda, a director of Enact Holdings, Inc. (ACT), was granted 168 deferred stock units on 09/08/2025. The units were recorded as an acquisition and are payable in shares of common stock one year after Ms. Hooda’s termination of service as a director. The filing notes additional deferred stock units were acquired through reinvestment of a dividend paid on 09/08/2025 at $0.21 per share. Following the reported transaction, the filing shows 30,378.457 shares beneficially owned. The Form 4 was filed by one reporting person and signed by a power of attorney on 09/10/2025.
Positive
- 168 deferred stock units granted to Director Sheila Hooda on 09/08/2025, aligning compensation with long‑term ownership
- Dividend reinvestment increased deferred units, recorded at $0.21 per share under the director award agreement
- Clear disclosure of beneficial ownership (30,378.457 shares) and transaction details in a timely Form 4 filing
Negative
- None.
Insights
TL;DR: Director compensation was satisfied with deferred stock units, aligning pay with long‑term ownership.
The Form 4 documents a routine director compensation transaction rather than a market sale or purchase of common shares. The grant of 168 deferred stock units, payable in common stock one year after termination, is consistent with retention and alignment practices used in board compensation plans. The reinvestment of a dividend at $0.21 per share increased deferred units under the director award agreement. This disclosure is procedural and does not indicate a change in control, major disposition, or immediate dilution event.
TL;DR: The filing shows a small, disclosed increase in director-held equity with no immediate cash proceeds or exercised derivatives.
The reported 168 deferred stock units are recorded as acquired on 09/08/2025 and carry a $0 reported price for the grant, with a separate note that dividend reinvestment occurred at $0.21 per share. The beneficial ownership reported is 30,378.457 shares direct. From a market-impact perspective, this is a minor, routine insider grant and does not constitute a material transaction likely to affect valuation or liquidity.